Saniona utser Robert Hoffman till ny styrelseledamot och ordförande för revisionsutskottet
16 sept. 2021 11h50 HE | Saniona AB
PRESSMEDDELANDE 16 september 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, tillkännager idag att styrelsen kompletteras med Robert...
VectivBio_Logo_RGB_Color.png
VectivBio Announces Upcoming Investor Events
16 sept. 2021 07h15 HE | VectivBio AG
BASEL, Switzerland, Sept. 16, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
1 (2).png
SHEPHERD Therapeutics Presents First Public Data at 2021 ESMO Congress Highlighting Ability of DELVE Computational Approach to Optimize Therapeutic Selection for Cancer Patients
16 sept. 2021 07h00 HE | SHEPHERD Therapeutics
BOSTON, Sept. 16, 2021 (GLOBE NEWSWIRE) -- SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for cancer patients, is pleased to present an e-poster of results from a...
Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Sparsentan in Europe, Australia and New Zealand
15 sept. 2021 16h05 HE | Travere Therapeutics, Inc.
Vifor Pharma obtains exclusive commercialization rights for sparsentan in Europe, Australia and New Zealand Travere receives a $55 million upfront payment and is eligible for additional regulatory...
Saniona utser Wendy Dwyer till Chief Business Officer
15 sept. 2021 08h00 HE | Saniona AB
PRESSMEDDELANDE 15 september 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, tillkännager idag rekryteringen av Wendy Dwyer till...
Saniona appoints Wendy Dwyer as Chief Business Officer
15 sept. 2021 08h00 HE | Saniona AB
PRESS RELEASE 15 September 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the appointment of Wendy Dwyer as Chief Business Officer....
Imara-Logo-Color-RGB.jpg
Imara to Participate in Upcoming Investor Conferences
15 sept. 2021 07h00 HE | Imara, Inc.
BOSTON, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
10 sept. 2021 08h03 HE | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
Decibel-full color-CMYK.png
Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
09 sept. 2021 07h30 HE | Decibel Therapeutics, Inc.
BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore...
VectivBio_Logo_RGB_Color.png
VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary
08 sept. 2021 07h15 HE | VectivBio AG
BASEL, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...